The Clinical Relevance of Force Platform Measures in Multiple Sclerosis: A Review

Yamamoto, D., & Campbell, J. D. (2012). Cost-Effectiveness of Multiple Sclerosis Disease-Modifying Therapies: A Systematic Review of the Literature. Autoimmune Diseases, 2012(), 375-387. https://doi.org/10.1155/2012/784364
Sbardella, E., Tona, F., Petsas, N., & Pantano, P. (2013). DTI Measurements in Multiple Sclerosis: Evaluation of Brain Damage and Clinical Implications. Multiple Sclerosis International, 2013(), 212-222. https://doi.org/10.1155/2013/671730
Winiarek, D. J. K., Szpakowski, P., & Glabinski, A. (2015). Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background. Neural Plasticity, 2015(), 375-385-031. https://doi.org/10.1155/2015/307175
Wang, P. J., Tseng, C. L., Young, C., Liu, H. M., Chang, Y. C., Shen, Y. Z., & Lee, C. Y. (1995). Multiple Sclerosis in Children: Clinical, Neuroimaging, and Neurophysiological Correlations. Acta Paediatrica Sinica, 36(2), 93-100. https://doi.org/10.7097/APS.199504.0093
Senders, A., Wahbeh, H., Spain, R., & Shinto, L. (2012). Mind-Body Medicine for Multiple Sclerosis: A Systematic Review. Autoimmune Diseases, 2012(), 252-263. https://doi.org/10.1155/2012/567324